12 Days of Christmas
Our festive run down of all the amazing things we've been able to fund following our partnership with Royal Mail.
Our annual Keynote Lecture showcases some of the latest advancements being made in stroke research.
This year’s Keynote Lecture was delivered by Professor Dame Nancy Rothwell, President and Vice-Chancellor of The University of Manchester. Professor Rothwell is one of the UK’s leading neuroscientists whose research focuses on inflammation in brain disease, especially stroke.
Active Lives After Stroke is a two-year project, funded by the National Lottery and awarded through Sport England, exploring how we can support stroke survivors to become active and stay active through attending support groups.
This project aims to find out if peer support can avert some of the adverse psychological consequences of aphasia: the language and communication disorder that affects about 15% of those who have a stroke. Stroke survivors with long-term aphasia will be trained as peer befrienders.
Amazing Brains: Research to Recovery. Previously known as our Keynote Lecture, our event took taking place on Wednesday, 15 May 2019, at the Science Museum in central London.
Today, the Association of Medical Research Charities (AMRC) launched a new spotlight report highlighting the positive difference medical research charities are making for mental health patients across the UK.
The Stroke Association is a member of the Association of Medical Research Charities (AMRC), which is the national membership organisation of leading medical and health research charities in the UK. Published today, the AMRC's 'Making a difference: Impact report 2017' highlights how the research of its member charities makes a difference.
Broadcaster, author and stroke survivor Andrew Marr is supporting a nationwide search for stroke survivors to enter the Stroke Association’s Life After Stroke Awards (LASA) 2016.
Early Supported Discharge (ESD) is the discharge of a stroke patient from hospital to their own home, co-ordinated by a team of therapists, nurses and a doctor. A number of ESD services have been set up across England. Do these services offer the same benefits to patients as those identified in clinical trials?